Abstract
Background
Protozoan parasites of the genus Trypanosoma cause disease in a wide range of mammalian hosts. Trypanosoma brucei brucei, transmitted by tsetse fly to cattle, causes a disease (Nagana) of great economic importance in parts of Africa. T. b. brucei also serves as a model for related Trypanosoma species, which cause human sleeping sickness.
Materials and Methods
Chalcone and acyl hydrazide derivatives are known to retard the growth of Plasmodium falciparum in vitro and inhibit the malarial cysteine proteinase, falcipain. We tested the effects of these compounds on the growth of bloodstream forms of T. b. brucei in cell culture and in a murine trypanosomiasis model, and investigated their ability to inhibit trypanopain-Tb, the major cysteine proteinase of T. b. brucei.
Results
Several related chalcones, acyl hydrazides, and amides killed cultured bloodstream forms of T. b. brucei, with the most effective compound reducing parasite numbers by 50% relative to control populations at a concentration of 240 nM. The most effective inhibitors protected mice from an otherwise lethal T. b. brucei infection in an in vivo model of acute parasite infection. Many of the compounds also inhibited trypanopain-Tb, with the most effective inhibitor having a Ki value of 27 nM. Ki values for trypanopain-Tb inhibition were up to 50- to 100-fold lower than for inhibition of mammalian cathepsin L, suggesting the possibility of selective inhibition of the parasite enzyme.
Conclusions
Chalcones, acyl hydrazides, and amides show promise as antitrypanosomal chemotherapeutic agents, with trypanopain-Tb possibly being one of their in vivo targets.
Similar content being viewed by others
References
Hall HTB. (1977) Disease and Parasites of Livestock in the Tropics. Longman, Harlow.
International Laboratory for Research on Animal Diseases. (1994) ILRAD 1993/4: Annual Report of the International Laboratory for Research on Animal Diseases. International Laboratory for Research on Animal Diseases, Nairobi, pp. 21–29.
Troeberg L, Morty RE, Pike RN, et al. (1999) Cysteine proteinase inhibitors kill cultured bloodstream forms of Trypanosoma brucei brucei Exp. Parsitol. 91: 349–355.
Ashall F, Angliker H, Shaw E. (1990) Lysis of trypanosomes by peptidyl fluoromethyl ketones. Biochim. Biophys. Res. Comm. 70: 923–929.
Engel JC, Doyle PS, Hsieh I, McKerrow JH. (1998) Cysteine proteinase inhibitors cure an experimental Trypanosoma cruzi infection. J. Exp. Med. 188: 725–734.
Mbawa ZR, Gumm ID, Shaw E, Lonsdale-Eccles JD. (1992) Characterisation of a cysteine protease from bloodstream forms of Trypanosoma congolense. Eur. J. Biochem. 204: 371–379.
Wasilewski MM, Lim KC, Phillips J, McKerrow JH. (1996) Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg production in vivo. Mol. Biochem. Parasitol. 81: 179–189.
Rosenthal PJ, Lee GK, Smith RE. (1993) Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria. J. Clin. Invest. 91: 1052–1056.
Rockett KA, Playfair JHL, Ashall F, Targett GAT, Angliker H, Shaw E. (1990) Inhibition of intraerythrocytic development of Plasmodium falciparum by proteinase inhibitors. FEBS Lett. 259: 257–259.
Selzer PM, Chen X, Chan VJ, et al. (1997) Leishmania major molecular modeling of cysteine proteases and prediction of new non-peptide inhibitors. Exp. Parasitol. 87: 212–221.
Harth G, Andrews N, Mills AA, Engel JC, Smith R, McKerrow JH. (1993) Peptide-fluoromethyl ketones arrest intracellular replication and intercellular transmission of Trypanosoma cruzi. Mol. Biochem. Parasitol. 58: 17–24.
Mierelles MNL, Juliano L, Carmona E, et al. (1992) Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro. Mol. Biochem. Parasitol. 52: 175–184.
Li R, Kenyon GL, Cohen FE, et al. (1995) In vitro antimalarial activity of chalcones and their derivatives. J. Med. Chem. 38: 5031–5037.
Torres-Santos EC, Moreira DL, Kaplan MAC, Meirelles MN, Rossi-Bergman B. (1999) Selective effect of 2′, 6′-dihydroxy-4′-methylchalcone isolated from Piper aduncum on Leishmania amazonensis. Antimicrob. Agents Chemother. 43: 1234–1241.
Ring CS, Sun E, McKerrow JH, et al. (1993) Structure-based inhibitor design by using protein models for the development of antiparasitic agents. Proc. Natl. Acad. Sci. U. S. A. 90: 3583–3587.
Li Z, Chen X, Davidson E, et al. (1994) Anti-malarial drug development using models of enzyme structure. Chem. Biol. 1: 31–37.
Kuntz ID. (1992) Structure-based strategies for drug design and discovery. Science 257: 1078–1082.
Hansch C, Leo AJ. (1979) In: Substituent Constants for Correlation Analysis in Chemistry and Biology. Wiley Interscience, New York.
Hesse F, Selzer PM, Mühlstädt K, Duszenko M. A novel cultivation technique for long-term maintenance of bloodstream form trypanosomes in vitro. Mol. Biochem. Parasitol. 70: 157–166.
Troeberg L, Pike RN, Morty RE, Berry RK, Coetzer THT, Lonsdale-Eccles JD. (1996) Proteases from Trypanosoma brucei brucei purification, characterisation and interactions with host regulatory molecules. Eur. J. Biochem. 238: 728–736.
Pike RN, Coetzer THT, Dennison C. (1992) Proteolytically active complexes of cathepsin L and a cysteine proteinase inhibitor; purification and demonstration of their formation in vitro. Arch. Biochem. Biophys. 294: 623–629.
Barrett AJ, Kirschke H. (1981). Cathepsin B, cathepsin H and cathepsin L. Methods Enzymol. 80C: 535–561.
Barrett AJ, Kembhavi AA, Brown MA, et al. (1982) L-trans-epoxysuccinyl-leucylamido(4-guanidino) butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem. J. 201: 189–198.
Salvesen G, Nagase K. (1989). Inhibition of proteolytic enzymes, p. 83–104. In: Benyon RJ, Bond JS (eds.) Proteolytic Enzymes: A Practical Approach. IRL Press, Oxford.
Dehrmann FM, Coetzer THT, Pike RN, Dennison C. (1995) Mature cathepsin L is substantially active in the ionic milieu of the extracellular medium. Arch. Biochem. Biophys. 324: 93–98.
Lipinski CA, Lombardo F, Dominy BW, Feeny PJ. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 23: 3–25.
Zhang K, Yang EB, Tang YW, Wong KP, Mack P. (1991) Inhibition of glutathione reductase by plant polyphenols. Biochem. Pharmacol. 54: 1047–1053.
McKerrow JH, McGrath ME, Engel JC. (1995) The cysteine protease of Trypanosoma cruzi as a model for antiparasitic drug design. Parasitol. Today 11: 279–282.
de Cazzulo F, MartInez BMJ, North MJ, Coombs MH, Cazzulo J–J. (1994) Effects of proteinase inhibitors on growth and differentiation of Trypanosoma cruzi. FEMS Microbiol. Lett. 124: 81–86.
Rosenthal PJ, McKerrow JH, Rasnick D, Leech JH. (1989) Plasmodium falciparum inhibitors of lysosomal cysteine proteinases inhibit a trophozoite proteinase and block parasite development. Mol. Biochem. Parasitol. 35: 177–184.
Acknowledgments
This work was supported by grants from the South African Foundation for Research Development and the University of Natal Research Fund (THTC), a Tropical Disease Research Unit Grant from the U.S. National Institute of Allergy and Infectious Diseases, and the Burroughs Wellcome Molecular Parasitology Scholar Award (JHMK).
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by F. E. Cohen.
Rights and permissions
About this article
Cite this article
Troeberg, L., Chen, X., Flaherty, T.M. et al. Chalcone, Acyl Hydrazide, and Related Amides Kill Cultured Trypanosoma brucei brucei. Mol Med 6, 660–669 (2000). https://doi.org/10.1007/BF03402046
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03402046